Furthermore, while PSMA is highly overexpressed in most prostate cancers and is clinically visualized using PSMA-specific probes, a recent study by Bakht et al. showed that the correlation is not perfect and there may also be active tracer uptake in tissue with low PSMA expression [25]. The gene discussed is FOLH1; the disease is prostate carcinoma.